Earnings ·
West Pharmaceutical Services, Inc. reported second-quarter 2026 results with net sales of $872.3 million, a 13.8%…
WSTWest Pharmaceutical Services Inc
West Pharmaceutical Services, Inc. reported second-quarter 2026 results with net sales of $872.3 million, a 13.8% increase compared to the prior year. Diluted earnings per share of $2.15 and adjusted-diluted EPS of $2.37 both increased year-over-year. Due to strong performance, the company is raising its full-year 2026 net sales guidance to a range of $3.345 billion to $3.380 billion and adjusted-diluted EPS guidance to $8.85 to $9.05. West Pharmaceutical Services, Inc. is a provider of injectable solutions and services for the pharmaceutical industry.